Page last updated: 2024-08-21

vancomycin and Cystic Fibrosis

vancomycin has been researched along with Cystic Fibrosis in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.50)18.7374
1990's2 (5.00)18.2507
2000's5 (12.50)29.6817
2010's21 (52.50)24.3611
2020's11 (27.50)2.80

Authors

AuthorsStudies
Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A1
Esquivel, MD; Finklea, JD; Monogue, ML; Sanders, JM; Smith, GS1
Crass, RL; Fitzgerald, LJ; Han, MK; Jia, S; Lenhan, BE; Lipp, MA; Patel, TS; Simon, RH1
Bhakta, Z; Gray, K; Leclair, L; Lindley, B; Watanabe, A; Young, DC1
Autry, E; Kormelink, L; Kuhn, R; Mitchell, B; Schadler, A1
Ceppe, A; Conlon, BP; Lu, KY; Muhlebach, MS; Velez, AZ; Wagner, NJ1
Bio, L; Brockmeyer, JM; Frymoyer, A; Schwenk, HT1
Epps, KL; Epps, QJ; Young, DC; Zobell, JT1
Frederick, CA; Fusco, NM; Meaney, CJ; Prescott, WA1
Hofmann, T; Jouhikainen, T; Lord, J; Waterer, G1
Benner, K; Branstetter, J; Crowder, C; Searcy, H; Troxler, B; Yarbrough, A1
Autry, EB; Beckman, EJ; Gardner, BM; Kuhn, RJ; Saad, A; Schadler, A; Studtmann, AE; Wurth, MA; Young, MR1
LeCleir, LK; Pettit, RS1
O'Toole, GA; Orazi, G1
Duman, D; Francisconi, R; Frederick, CA; Fusco, NM; Meaney, CJ; Prescott, WA1
Esther, CR; McKinzie, CJ; Vece, TJ1
Amin, RW; Guttmann, RP; Harris, QR; Thomas, JW1
Bogdan, C; Kiefer, A; Melichar, VO1
Fusco, NM; Meaney, CJ; Prescott, WA1
Boyle, MP; Chmiel, JF; Dasenbrook, EC; Dezube, R; Diener-West, M; Jennings, MT; Rykiel, M1
Bernstein, AT; Esther, CR; Goralski, JL; Leigh, MW; McKinzie, CJ1
Ampofo, K; Frymoyer, A; Hersh, AL; Liu, X; Lubsch, L; Olson, J; Rashid, J; Sherwin, CMT; Stockmann, C; Wang, Y; Young, DC; Zobell, JT1
Ampofo, K; Lubsch, L; Noyes, BE; Olson, J; Sherwin, CM; Spigarelli, MG; Stockmann, C; Young, DC; Zobell, JT1
Boyle, MP; Callahan, KA; Dasenbrook, EC; Jennings, MT; Weaver, D1
Ampofo, K; Chin, MJ; Dasenbrook, E; Epps, KL; Marshall, BC; Montague, M; Olson, J; Young, DC; Zobell, JT1
Fusco, NM; Prescott, WA; Toussaint, KA1
Durham, SH; Eiland, LS; Garza, KB1
Feilcke, M; Forstner, M; Griese, M; Hector, A; Hengst, M; Kappler, M; Kröner, C; Naehrig, S; Nagel, F; Pawlita, I; Ripper, J; von Both, U1
Carroll, K; Cohen, DM; Cross, CP; Feeney, MP; Garinis, AC; Gold, JA; Hunter, LL; Keefe, DH; Putterman, DB; Srikanth, P; Steyger, PS1
Barker, HC; Bilton, D; Haworth, CS; Roberts, P; Williams, D1
Feola, DJ; Hayes, D; Mullett, TW; Murphy, BS1
Bossé, D; Cantin, AM; Lemire, C; Ménard, F; Ruel, J; Valiquette, L1
Fung, L1
Jamerson, PA; Wilson, K1
Brown, D; Heaf, DP; Hughes, J; Solís, A; Van Saene, HK1
Chu, C; Greenberg, DP; Hussain, SZ; Khan, S; Orenstein, D1
Knowles, MR; Michalets, EL; Pleasants, RA; Rehm, JR; Samuelson, WM; Williams, DM1
Baquero, F; Cantón, R; Escobar, H; Máiz, L; Mir, N1
Handke, R; Schmitt-Grohé, S; Steffan, J; Wiggert, E; Zielen, S1
Kuriyama, S; Panosian, C1

Reviews

3 review(s) available for vancomycin and Cystic Fibrosis

ArticleYear
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
    Pediatric pulmonology, 2020, Volume: 55, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2020
Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
    The Annals of pharmacotherapy, 2015, Volume: 49, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin

2015
Respiratory pharmacology. Antibiotics. II. Aminoglycosides, polymyxins, vancomycin, trimethoprim-sulfamethoxazole, and pentamidine.
    Clinics in chest medicine, 1986, Volume: 7, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cystic Fibrosis; Drug Combinations; Drug Resistance, Microbial; Humans; Pentamidine; Pneumonia; Polymyxins; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

1986

Trials

5 trial(s) available for vancomycin and Cystic Fibrosis

ArticleYear
Phase I, Dose-Escalating Study of the Safety and Pharmacokinetics of Inhaled Dry-Powder Vancomycin (AeroVanc) in Volunteers and Patients with Cystic Fibrosis: a New Approach to Therapy for Methicillin-Resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3

    Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Cystic Fibrosis; Dry Powder Inhalers; Female; Forced Expiratory Volume; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Patient Safety; Powders; Staphylococcal Infections; Vancomycin

2020
Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2019, Volume: 18, Issue:3

    Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Cystic Fibrosis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Treatment Outcome; Vancomycin

2019
Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial.
    Trials, 2014, Jun-12, Volume: 15

    Topics: Adolescent; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child; Cystic Fibrosis; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Nebulizers and Vaporizers; Remission Induction; Research Design; Rifampin; Staphylococcal Infections; Vancomycin

2014
Comparison of central venous catheter and peripheral vein samples of antibiotics in children with cystic fibrosis.
    Journal for specialists in pediatric nursing : JSPN, 2013, Volume: 18, Issue:1

    Topics: Adolescent; Catheterization, Central Venous; Catheterization, Peripheral; Child; Child, Preschool; Cohort Studies; Cystic Fibrosis; Drug Monitoring; Female; Hospitals, Pediatric; Humans; Male; Sensitivity and Specificity; Specimen Handling; Tobramycin; Vancomycin

2013
Pharmacokinetics of vancomycin in adult cystic fibrosis patients.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Bayes Theorem; Cystic Fibrosis; Female; Humans; Male; Respiratory Tract Infections; Vancomycin

1996

Other Studies

32 other study(ies) available for vancomycin and Cystic Fibrosis

ArticleYear
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine

2009
Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults.
    Journal of global antimicrobial resistance, 2022, Volume: 28

    Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cohort Studies; Cystic Fibrosis; Humans; Lung; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin

2022
Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin.
    The Journal of antimicrobial chemotherapy, 2022, 08-25, Volume: 77, Issue:9

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin

2022
Pharmacokinetics of intermittent dosed intravenous vancomycin in adult persons with cystic fibrosis.
    Pediatric pulmonology, 2022, Volume: 57, Issue:11

    Topics: Acute Kidney Injury; Adult; Animals; Anti-Bacterial Agents; Cystic Fibrosis; Hominidae; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin

2022
Retrospective review of vancomycin monitoring via trough only versus two-point estimated area under the curve in pediatric and adult patients with cystic fibrosis.
    Pediatric pulmonology, 2023, Volume: 58, Issue:1

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Area Under Curve; Child; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin

2023
Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections.
    Microbiology spectrum, 2023, 02-14, Volume: 11, Issue:1

    Topics: Anti-Bacterial Agents; Cystic Fibrosis; Hemolysis; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Treatment Outcome; Vancomycin

2023
Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis.
    Pharmacotherapy, 2023, Volume: 43, Issue:10

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Child; Cystic Fibrosis; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin

2023
Comparative Effectiveness of Vancomycin Versus Linezolid for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis.
    The Annals of pharmacotherapy, 2020, Volume: 54, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Cohort Studies; Cystic Fibrosis; Disease Progression; Female; Hospitalization; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Respiratory Function Tests; Retrospective Studies; Treatment Outcome; Vancomycin

2020
Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis.
    Pediatric pulmonology, 2020, Volume: 55, Issue:12

    Topics: Administration, Intravenous; Adolescent; Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin; Young Adult

2020
Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis.
    Pediatric pulmonology, 2020, Volume: 55, Issue:12

    Topics: Acute Kidney Injury; Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Colistin; Cystic Fibrosis; Female; Humans; Incidence; Infant; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Retrospective Studies; Risk Factors; Tobramycin; Vancomycin; Young Adult

2020
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
    Pediatric pulmonology, 2017, Volume: 52, Issue:8

    Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin

2017
    mBio, 2017, 07-18, Volume: 8, Issue:4

    Topics: Anti-Bacterial Agents; Biofilms; Biological Factors; Cells, Cultured; Cystic Fibrosis; Humans; Hypoxia; Microbial Interactions; Models, Biological; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin

2017
Association of Vancomycin Trough Concentration With Response to Treatment for Acute Pulmonary Exacerbation of Cystic Fibrosis.
    Journal of the Pediatric Infectious Diseases Society, 2017, Sep-01, Volume: 6, Issue:3

    Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Child; Cohort Studies; Cystic Fibrosis; Female; Humans; Linear Models; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multivariate Analysis; Respiratory Function Tests; Retrospective Studies; Staphylococcal Infections; Vancomycin; Young Adult

2017
Continuous vancomycin in a pediatric cystic fibrosis patient.
    Pediatric pulmonology, 2018, Volume: 53, Issue:1

    Topics: Anti-Bacterial Agents; Child; Cystic Fibrosis; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin

2018
Prediction of Vancomycin Dose for Recommended Trough Concentrations in Pediatric Patients With Cystic Fibrosis.
    Journal of clinical pharmacology, 2018, Volume: 58, Issue:5

    Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Dose-Response Relationship, Drug; Humans; Infant; Methicillin-Resistant Staphylococcus aureus; Models, Biological; Regression Analysis; Retrospective Studies; Staphylococcal Infections; Vancomycin

2018
Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.
    BMC pulmonary medicine, 2018, Jan-25, Volume: 18, Issue:1

    Topics: Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Baths; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Fusidic Acid; Hand Disinfection; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Retrospective Studies; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult

2018
Pharmacokinetic Monitoring of Vancomycin in Cystic Fibrosis: Is It Time to Move Past Trough Concentrations?
    The Pediatric infectious disease journal, 2019, Volume: 38, Issue:3

    Topics: Adolescent; Area Under Curve; Child; Cystic Fibrosis; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Vancomycin

2019
Use of telavancin in adolescent patients with cystic fibrosis and prior intolerance to vancomycin: A case series.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2018, Volume: 17, Issue:6

    Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Child; Cross Infection; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Lipoglycopeptides; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Treatment Outcome; Vancomycin

2018
An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus.
    Journal of clinical pharmacology, 2019, Volume: 59, Issue:2

    Topics: Adolescent; Area Under Curve; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pharmacokinetics; Vancomycin

2019
Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
    Pharmacotherapy, 2013, Volume: 33, Issue:12

    Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Body Weight; Child; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Models, Biological; Nonlinear Dynamics; Staphylococcal Infections; Tissue Distribution; Vancomycin

2013
Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Pediatric pulmonology, 2015, Volume: 50, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Child; Cross-Sectional Studies; Cystic Fibrosis; Drug Administration Schedule; Drug Therapy, Combination; Health Care Surveys; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Practice Patterns, Physicians'; Rifampin; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2015
Relationship between vancomycin dosage and serum trough vancomycin concentrations in pediatric patients with cystic fibrosis.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2016, Jul-01, Volume: 73, Issue:13

    Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Infusions, Intravenous; Male; Patient Admission; Retrospective Studies; Vancomycin

2016
Eradication of methicillin resistant Staphylococcus aureus detected for the first time in cystic fibrosis: A single center observational study.
    Pediatric pulmonology, 2016, Volume: 51, Issue:10

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult

2016
The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2017, Volume: 16, Issue:3

    Topics: Adolescent; Adult; Age Factors; Amikacin; Anti-Bacterial Agents; Audiometry, Pure-Tone; Bacterial Infections; Cystic Fibrosis; Female; Hearing Loss; Humans; Male; Middle Aged; Patient Outcome Assessment; Sex Factors; Time; Tobramycin; United States; Vancomycin

2017
Clostridium difficile pancolitis in adults with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2008, Volume: 7, Issue:5

    Topics: Adult; Clostridioides difficile; Cystic Fibrosis; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Steroids; Vancomycin

2008
Aerosolized vancomycin for the treatment of MRSA after lung transplantation.
    Respirology (Carlton, Vic.), 2010, Volume: 15, Issue:1

    Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Lung Transplantation; Male; Methicillin-Resistant Staphylococcus aureus; Postoperative Complications; Staphylococcal Infections; Vancomycin

2010
Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
    Infection, 2013, Volume: 41, Issue:2

    Topics: Administration, Oral; Adult; Anaphylaxis; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cystic Fibrosis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Vancomycin

2013
Continuous infusion vancomycin for treatment of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:10

    Topics: Adolescent; Anti-Bacterial Agents; Child, Preschool; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin

2012
Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol.
    Pediatric pulmonology, 2003, Volume: 36, Issue:3

    Topics: Administration, Topical; Anti-Bacterial Agents; Carrier State; Cephradine; Child; Cystic Fibrosis; Female; Hand Disinfection; Humans; Infection Control; Male; Methicillin Resistance; Oropharynx; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2003
Clostridium difficile colitis in children with cystic fibrosis.
    Digestive diseases and sciences, 2004, Volume: 49, Issue:1

    Topics: Adolescent; Clostridioides difficile; Cystic Fibrosis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Humans; Male; Tomography, X-Ray Computed; Vancomycin

2004
Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Pediatric pulmonology, 1998, Volume: 26, Issue:4

    Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Child; Cystic Fibrosis; Humans; Lung Diseases; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1998
Severe antibiotic-associated colitis in a patient with cystic fibrosis and colonic wall thickening.
    Journal of pediatric gastroenterology and nutrition, 2002, Volume: 34, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Colon; Cystic Fibrosis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Metronidazole; Recurrence; Tomography, X-Ray Computed; Ultrasonography; Vancomycin

2002